Essential roles of the Fas ligand in the development of hepatitis

Author:  ["Toru Kondo","Takashi Suda","Hidehiro Fukuyama","Masashi Adachi","Shigekazu Nagata"]

Publication:  Nature Medicine

CITE.CC academic search helps you expand the influence of your papers.

Tags:     Medicine

Abstract

The Fas ligand (FasL) is expressed in activated T cells and induces apoptosis in Fas-bearing cells. A cytotoxic T lymphocyte (CTL) clone specific for hepatitis B surface antigen (HBsAg) causes an acute liver disease in HBsAg transgenic mice. Here we observed that the CTL clone killed hepatocytes expressing HBsAg in a Fas-dependent manner. Administration of the soluble form of Fas into HBsAg transgenic mice prevented the CTL-induced liver disease. In the second model, mice were primed with Propionibacterium acnes. A subsequent challenge with lipopolysaccharide (LPS) killed the mice by inducing liver injury. Neutralization of FasL rescued the mice from LPS-induced mortality, and Fas-null mice were resistant to LPS-induced mortality. These results suggest that FasL has an essential role in the development of hepatitis.

Cite this article

Kondo, T., Suda, T., Fukuyama, H. et al. Essential roles of the Fas ligand in the development of hepatitis. Nat Med 3, 409–413 (1997). https://doi.org/10.1038/nm0497-409

View full text

>> Full Text:   Essential roles of the Fas ligand in the development of hepatitis

Effective tumor vaccines generated by in vitro modification of tumor cells with cytokines and bispec

Neurotrophic actions of nonimmunosuppressive analogues of immunosuppressive drugs FK506, rapamycin a